Histidine-rich glycoprotein plus zinc to neutralize heparin

Journal of Laboratory and Clinical Medicine

Volumn 139, Issue 4, 2002, Pages 211-217

  Fu, Chieh Lin ^a   Horn, McDonald K ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDOTE; CITRIC ACID; HEPARIN; HEPARIN ANTAGONIST; HISTIDINE RICH PROTEINS; HISTIDINE-RICH PROTEINS; PLASMA PROTEIN; PROTEIN; ZINC;

ARTICLE; BLOOD CLOTTING; DRUG EFFECT; DRUG POTENTIATION; HUMAN; IN VITRO STUDY; METABOLISM; PROTEIN BINDING; THROMBIN TIME;

ANTIDOTES; BLOOD COAGULATION; BLOOD PROTEINS; CITRATES; DRUG SYNERGISM; HEPARIN; HEPARIN ANTAGONISTS; HUMANS; PROTEIN BINDING; PROTEINS; THROMBIN TIME; ZINC;

EID: 0036014146     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1067/mlc.2002.121854     Document Type: Article

References (30)

1. Interaction of histidine-proline-rich glycoprotein with plasminogen: Effect of ligands, pH, ionic strength, and chemical modification
2. Interaction of histidine-rich glycoprotein with fibrinogen and fibrin
3. Platelet thrombospondin forms a trimolecular complex with plasminogen and histidine-rich glycoprotein
4. Neutralization of heparin activity by binding to human histidine-rich glycoprotein
5. Interactions of the histidine-rich glycoprotein of serum with metals
6. The histidine-rich glycoprotein of serum has a domain rich in histidine, proline, and glycine that binds heme and metals
7. Histidine-proline-rich glycoprotein as a plasma pH sensor
8. Further characterization of the interaction of histidine-rich glycoprotein with heparin: Evidence for the binding of two molecules of histidine-rich glycoprotein by high molecular weight heparin and for the involvement of histidine residues in heparin binding
9. Histidine-rich glycoprotein modulation of the anticoagulant activity of heparin
10. Zinc as a cofactor for heparin neutralization by histidine-rich glycoprotein
11. Histidine-rich glycoprotein modulates the anticoagulant activity of heparin in human plasma
12. Interaction of immobilised unfractionated and LMW heparins with proteins in whole human plasma
13. The heparin-protamine interaction
14. The interaction of zinc, nickel and cadmium with serum albumin and histidine-rich glycoprotein assessed by equilibrium dialysis and immunoadsorbent chromatography
15. Zinc
16. General clinical tests
17. 2-macroglobulin bound zinc concentrations in the sera of healthy adults
18. Histidine-proline-rich glycoprotein binding to platelets mediated by transition metals
19. Isolation and characterization of antithrombin III from human, porcine, and rabbit plasma, and rabbit serum
20. Antithrombin III Basel: Identification of a pro-leu substitution in a hereditary abnormal antithrombin with impaired heparin cofactor activity
21. Pentosan-induced thrombocytopenia: Support for an immune complex mechanism
22. Comparison of the effect of histidine-rich glycoprotein and 6-aminohexanoic acid on plasmin production and fibrinolysis in vitro
23. A simple rate law that describes the kinetics of the heparin-catalyzed reaction between antithrombin III and thrombin
24. The procoagulant effect of zinc on fibrin clot formation
25. Binding of zinc ions to heparin
26. Acute intravenous zinc poisoning
27. Zinc gluconate: Acute ingestion
28. Acute zinc toxicity in haemodialysis
29. High levels of histidine-rich glycoprotein and thrombotic diathesis
30. Human histidine-rich glycoprotein in SF9 insect cells inhibits apatite formation